Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 3-[4-[(2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholin-4-yl]piperidin-1-yl]-1H-1,2,4-triazol-5-amine | 2088453-21-6 | 99.9% | 390.9 g·mol⁻1 | C19H27ClN6O | 5 MG
SDP

Catalog No. 5000223437
Encompass_Preferred

OATD-01 is a first-in-class, orally active small-molecule inhibitor of chitinase enzymes (CHIT1 and AMCase) with low-nanomolar potency and demonstrated antifibrotic efficacy in preclinical models. Developed for treatment of fibrotic and inflammatory pulmonary diseases, it has progressed into clinical studies and is supplied for research use in biochemical, cellular, and in vivo pharmacology. CAS 2088453-21-6; molecular formula C19H27ClN6O.

  • Inhibits CHIT1 and AMCase with low-nanomolar potency.
  • Orally bioavailable small molecule suitable for in vivo studies.
  • Demonstrated antifibrotic activity in multiple preclinical models.
  • High-purity material provided for research applications.
  • Useful for pharmacokinetic and pharmacodynamic investigations.

Catalog No. 50-002-23437 Supplier Medchemexpress LLC Supplier No. HY137464A5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

OATD-01 is a first-in-class, orally active small-molecule inhibitor of chitinase enzymes (CHIT1 and AMCase) with low-nanomolar potency and demonstrated antifibrotic efficacy in preclinical models. Developed for treatment of fibrotic and inflammatory pulmonary diseases, it has progressed into clinical studies and is supplied for research use in biochemical, cellular, and in vivo pharmacology. CAS 2088453-21-6; molecular formula C19H27ClN6O.

  • Inhibits CHIT1 and AMCase with low-nanomolar potency.
  • Orally bioavailable small molecule suitable for in vivo studies.
  • Demonstrated antifibrotic activity in multiple preclinical models.
  • High-purity material provided for research applications.
  • Useful for pharmacokinetic and pharmacodynamic investigations.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.